Molecular Screening for <i>Chlamydia trachomatis</i> among Pregnant Women Attending Ante-Natal Clinics in Kaduna Metropolis, Kaduna State, Nigeria

Authors

  • Nkechi Egbe Nigerian Defence Academy, Kaduna
  • BF Bakori Department of Biological Science, Nigerian Defence Academy, PMB 2109 Kaduna
  • MI Abdulsalam Department of Biotechnology, Nigerian Defence Academy, PMB 2109 Kaduna
  • GL Mulade Department of Biotechnology, Nigerian Defence Academy, PMB 2109 Kaduna

DOI:

https://doi.org/10.60787/tnhj.v24i4.913

Keywords:

Chlamydia trachomatis, ELISA, PCR, pregnant women, antenatal clinics, Kaduna metropolis

Abstract

Background: Chlamydia trachomatis infection causes pelvic inflammatory disease and infertility and in pregnant women, it is associated with ectopic pregnancy and abortion. One of the key factors in the prevention of C. trachomatis infection is the availability of specific laboratory diagnostics with high sensitivity. For economic reasons, serology is the method routinely used for detection of the bacteria in clinical settings in Nigeria. This study was undertaken to investigate the prevalence of infection with Chlamydia trachomatis among pregnant women attending antenatal clinics in Hospitals within Kaduna metropolis using serological and molecular techniques.

 

Method: A cross-sectional study design was implemented in this study. The study recruited 200 pregnant women. Serology was carried out by ELISA technique to detect chlamydia antibody in the sera of subjects. For molecular technique, Bacterial DNA was isolated from ten sera samples that showed positive results with ELISA and the omp1 gene of Chlamydia trachomatis was amplified with specific primers using conventional PCR.

 

Results: Of the 200 sera samples tested for C. trachomatis by ELISA, 19 (9.5%) samples gave positive results, while only 4 of the 10 samples tested by PCR returned positive for C. trachomatis.

 

Conclusion: This data suggests that PCR method is much more specific compared to the serological approach routinely used in diagnosis of the disease, thereby recommending that nucleic acid testing should be incorporated into the diagnosis of this pathogen in clinics and hospitals in developing countries like Nigeria.

Downloads

Download data is not yet available.

References

Bugalhão JN, Mota LJ. The multiple functions of the numerous Chlamydia trachomatis secreted proteins: the tip of the iceberg. Microbial Cell. 2019;6(9):414.

Qureshi NS. Chlamydia (Chlamydial genitourinary infections) medication [Internet]. 2024. Available from: https://emedicine.medscape.com/article/214823-medication?form=fpf

Olaleye AO, Babah OA, Osuagwu CS, Ogunsola FT, Afolabi BB. Sexually transmitted infections in pregnancy–An update on Chlamydia trachomatis and Neisseria gonorrhoeae. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020; 255:1–12.

Ling H, Luo L, Dai X, Chen H. Fallopian tubal infertility: The result of Chlamydia trachomatis-induced fallopian tubal fibrosis. Mol Cell Biochem. 2022;1–8.

Özlem Özdemir-Karabağ A. Chlamydia: The Female Reproductive System and Infertility. Infectious Diseases. IntechOpen; 2023. Available from: http://dx.doi.org/10.5772/intechopen.111756

Reid J. Pelvic inflammatory disease and other upper genital infections. In: Handbook of Gynecology. Vol. 1. Springer International Publishing; 2023: 335-345.

Darville T. Chlamydia infections. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA, editors. Remington and Klein’s Infectious Diseases of the Fetus and Newborn Infant. 9th ed. Elsevier; 2024: 495-500.

Metallinou D, Nanou C, Sarantaki A, Lazarou E, Liagkou A, Lykeridou K. Chlamydial Infection. In: Primary Health Care. IntechOpen; 2021. Available from: http://dx.doi.org/10.5772/intechopen.96501

Siakwa M, Bruce S, Owoo H, Mills J. Trans- Placental Transmission and Survival at Birth among Neonates of Chlamydia trachomatis Infected Mothers: A Cohort Study. Authorea Preprints. 2020; DOI: 10.22541/au.159818290.04073936

Berestoviy VO, Mahmood A, Venckivska IB, Ginzburg VG, Sokol I V, Berestoviy OO, et al. The overview and role of heat shock proteins (HSP) especially HSP 60 and 70 in reproduction and other pathologies (a literature review). Медичні перспективи. 2021;26(1):54–62.

Niu, S, Huang, S, & Liu, B. Chlamydia trachomatis. In: Tang YW, Hindiyeh MY, Liu D, Sails A, Spearman P, Zhang J.-R, editors. Molecular medical microbiology. 3rd ed. Academic Press; 2024 p. 1343-1356. https://doi.org/10.1016/B978-0-12-818619-0.00049-6

Chernesky MA. The laboratory diagnosis of Chlamydia trachomatis infections. Canadian Journal of Infectious Diseases and Medical Microbiology. 2005;16(1):39–44.

Sethi S, Roy A, Garg S, Venkatesan LS, Bagga R. Detection of Chlamydia trachomatis infections by polymerase chain reaction in asymptomatic pregnant women with special reference to the utility of the pooling of urine specimens. Indian Journal of Medical Research. 2017;146(Suppl 1):S59–63.

Cui L, Qu G, Chen Y, Wu Y, Wang C, Cheng H, et al. Polymorphic membrane protein 20G: a promising diagnostic biomarker for specific detection of Chlamydia psittaci infection. Microb Pathog. 2021; 155:104882.

Oyetunji O, Tukur J, Abdurrahman A. Chlamydia Trachomatis Antibody Titre Association with Tubal Pathology among Infertile Women in a Tertiary Care Facility in Nigeria. Trop J Obstet Gynaecol. 2021;38(2):154–60.

Abdella RMA, Abdelmoaty HI, Elsherif RH, Sayed AM, Sherif NA, Gouda HM, et al. Screening for Chlamydia trachomatis in Egyptian women with unexplained infertility, comparing real-time PCR techniques to standard serology tests: case control study: Chlamydia trachomatis and unexplained infertility. BMC Womens Health. 2015; 15:1–8.

Sethi S, Roy A, Garg S, Venkatesan LS, Bagga R. Detection of Chlamydia trachomatis infections by polymerase chain reaction in asymptomatic pregnant women with special reference to the utility of the pooling of urine specimens. Indian Journal of Medical Research. 2017;146(Suppl 1):S59–63.

Konuk EY. Molecular Approaches to the Diagnosis of Chlamydia. In: Chlamydia-Secret Enemy from Past to Present. IntechOpen; 2023.

Mylonas I. Female genital Chlamydia trachomatis infection: where are we heading? Arch Gynecol Obstet. 2012; 285:1271–85.

Pipal VR, Pipal R, Pipal D, Yadav S, Kamal M, Singariya G. Seroprevalence of Chlamydia trachomatis infection among pregnant women and their outcome. Int J Reprod Contracept Obstet Gynecol. 2017;6(3):1017.

National Academies of Sciences, Engineering, and Medicine; Crowley JS, Geller AB, Vermund SH, editors. Sexually Transmitted Infections: Adopting a Sexual Health Paradigm. STI Screening and Treatment Guidelines Issued by Health Professional Societies. Washington (DC): National Academies Press (US); 2021 Mar 24. https://doi.org/10.17226/25955

Harkins AL, Munson E. Molecular diagnosis of sexually transmitted Chlamydia trachomatis in the United States. Int Sch Res Notices. 2011;2011(1):279149.

Behrozi R, Badami N. Assessment of prevalence of chlamydial infection in women pregnant referring the hospitals of Tehran University of Medical Sciences in 1994 years. Journal of Mazandaran University of Medical Sciences. 1999;22–3.

O’Connell CM, Ferone ME. Chlamydia trachomatis genital infections. Microbial cell. 2016;3(9):390.

Bamikole HT, Idemudia IB, Imariagbe EE, Ekhaise FO. The prevalence of Chlamydia trachomatis amongst asymptomatic pregnant women in four local government areas of Delta state. African Journal of Health, Safety and Environment. 2020;1(2):13–23.

Downloads

Published

2024-12-31

How to Cite

Egbe, N., Bakori, B., Abdulsalam, M., & Mulade, G. (2024). Molecular Screening for <i>Chlamydia trachomatis</i> among Pregnant Women Attending Ante-Natal Clinics in Kaduna Metropolis, Kaduna State, Nigeria. The Nigerian Health Journal, 24(4), 1746–1752. https://doi.org/10.60787/tnhj.v24i4.913

Issue

Section

Original Articles
Abtract Views | PDF Download | EPUB Download: 17 / 4 / 0

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.